Chemical Structure (Olanzapine Inj 1)
Olanzapine Injection, Powder, For Solution
Product Images NDC 0121-1072
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0121-1072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Olanzapine For Injection Carton Ndc 0121-1072-55 (Olanzapine Inj 2)
Each vial of Olanzapine contains 10 mg of the active ingredient. Upon reconstitution with sterile water, each mL will contain 5mg of Olanzapine. The product should be stored at controlled room temperature, and after reconstitution, it should be used immediately or stored at room temperature for up to 1 hour. The solution should appear clear and yellow, and it should be protected from light. The reconstitution instructions and method of administration can be found in the accompanying literature. This Olanzapine injection is for intramuscular use only and is distributed by PAI Pharma in the USA.*
Olanzapine For Injection Vial Ndc 0121-1072-55 (Olanzapine Inj 3)
This text appears to be a description of a pharmaceutical product, specifically Olanzapine for injection. The medication is in the form of a 10 mg/vial intended for intramuscular use only. It is a single-dose vial distributed by PAI Pharma and has instructions for dosage, reconstitution, and method of administration provided in accompanying literature. The product is made in Taiwan and distributed by PAI Pharma based in Greenville, SC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
